Acadia Pharmaceuticals Inc (ACAD) Live Stock Price, Forecast & News | FX Empire

Advertisement

Advertisement

Acadia Pharmaceuticals Inc
ACAD
(Nasdaq - US)
N/A
19.14
+0.59 (+3.18%)
in:usd•As of: Jul 26, 2024 15:59 UTC -4
Open
18.64
High
19.20
Low
18.64

Stats

Prev. Close

18.55

Open

18.64

Day's Range

18.64 - 19.20

52 Week Range

14.55 - 32.59

YTD Change

-38.87%

1 Year Change

-35.34%

Market Cap

3.16B

P/E Ratio

N/A

Volume

95,451

Beta

0.38

Sector

Health Technology

Industry

Pharmaceuticals Major

Economic CalendarAll Events

Time zone: GMT

Friday, July 26th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:30	USD	Core PCE Price Index MoMJun	High	0.2%	0.1%	0.1%
12:30	USD	Personal Spending MoMJun	High	0.3%	0.3%	0.4%
12:30	USD	Personal Income MoMJun	High	0.2%	0.4%	0.4%
14:00	USD	Michigan Consumer Sentiment FinalJul	Medium	66.4	66	68.2

Monday, July 29th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
14:30	USD	Dallas Fed Manufacturing IndexJul	Medium		-12	-15.1
19:00	USD	Treasury Refunding Financing Estimates	Medium

Tuesday, July 30th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
13:00	USD	S&P/Case-Shiller Home Price YoYMay	Medium		6.9%	7.2%

Latest News

featured

Zacks Investment ResearchJul 16, 2024

HLN vs. LMAT: Which Stock Should Value Investors Buy Now?

ACAD+3.18%

featured

Zacks Investment ResearchJul 16, 2024

Acadia's (ACAD) Nuplazid Drives Growth, Pipeline Setbacks a Woe

ACAD+3.18%

featured

Seeking AlphaJun 23, 2024

Acadia Pharmaceuticals: Back In The Buy Zone

ACAD+3.18%

featured

Zacks Investment ResearchJun 7, 2024

Acadia (ACAD) Up 0.6% Since Last Earnings Report: Can It Continue?

ACAD+3.18%

featured

Seeking AlphaJun 6, 2024

Acadia Pharmaceuticals: Bullish On Nuplazid And Daybue Driven Growth In CNS Treatments

ACAD+3.18%

featured

Zacks Investment ResearchMay 9, 2024

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss

Data Vendor: Xignite Logo

Stocks

Loading

Loading

Trade With A Regulated Broker